Charles River Laboratories was awarded a five-year, $95.7 million contract by the National Institute of Allergy and Infectious Diseases (NIAID). Under NIAID’s Division of Intramural Research animal care program, Charles River will manage and provide staffing for NIAID’s on-site vivarium and related research model operations. The program is required to ensure the humane care and use of research models, and the efficient management of NIAID’s research model operations.
 
James C. Foster, chairman, president and chief executive officer of Charles River, said, “We are very pleased to be awarded this significant contract by NIAID and look forward to establishing a collaborative relationship to support NIAID’s critical biomedical research programs across a range of scientific disciplines. Charles River’s focus on science, research model care, and productivity will enable NIAID to streamline its research by delivering operational and cost efficiencies through strategic insourcing. We believe that an increasing number of government and academic institutions, as well as biopharmaceutical clients, understand the value of utilizing our flexible and efficient staffing solutions.” 
 
The contract commenced on September 2018. The initial period of the contract runs through September 2019, and includes annual renewal options to extend the contract for an additional four years through September 2023. Charles River expects this new contract to generate incremental revenue of approximately $18 million over the initial twelve-month period.